Listed by the USPTO as BARRERA, IMMACULADA
Tech Center 1600 • Art Units: 1671 1672
This examiner grants 30% of resolved cases
BARRERA, IMMACULADA works in Tech Center 1600 and Art Unit 1671. The profile contains 30 resolved cases, with a 30.0% allowance rate and an 80.8% interview lift. The strong interview association makes direct examiner engagement a central consideration, although the case record is limited.
The median time to allowance is 1311 days. Janssen Pharmaceuticals Inc., Riken, and National University of Singapore are the listed companies. The listed firms are SUGHRUE MION, PLLC, BakerHostetler, and DINSMORE & SHOHL LLP.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18261427 | SAMPLE LYSIS REAGENT COMPOSITIONS AND METHODS OF PRODUCTION AND USE THEREOF | Final Rejection | Siemens Healthcare Diagnostics Inc. |
| 18021262 | Pharmaceutical Composition Comprising Hepatitis B Virus-Derived Polypeptide for Prevention or Treatment of Cancer | Non-Final OA | SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy30.0% of resolved applications examined by Immaculada Barrera were allowed (30 resolved cases), compared with 39.7% across Art Unit 1671 over the last five years.
This examiner's interview lift is +80.8 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Immaculada Barrera took 1,311 days on average from filing to allowance.
Immaculada Barrera examines applications in Art Unit 1671 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
